EDITORIAL
EULAR
A good year for European rheumatology
Correspondence to:
Correspondence to:
T K Kvien
EULAR President, Department of Rheumatology, Diakonhjemmet Hospital, Box 23 Vinderen, N-0319 Oslo, Norway; t.k.kvien@medisin.uio.no
| The first 150 words of the full text of this article appear below. |
I am pleased to be able to summarise 2006 as a year of further advances in European rheumatology.
EULAR was very satisfied with the large number of attendants at the European Congress of Rheumatology in Amsterdam in June. We had more than 11 000 delegates from 107 different countries; 3030 abstracts were submitted; 215 were accepted as oral presentations and 1825 as posters.
An important goal of EULAR is to raise the awareness of rheumatic diseases. Our lobbing campaign in Brussels seems to be successful as rheumatic diseases will have a more prominent mention in the research framework program 7, but we need to continuously influence the allocation of research money in the direction of rheumatic diseases in the forthcoming calls for applications.
EULAR is fostering research and educational activities that will ultimately lead to the better treatment and care of patients. We have supported several multinational European research
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
